Navigation Links
Community-acquired MRSA cases on the rise in New York City, study suggests

CHICAGO (June 12, 2012) Hospitalization rates in New York City for patients with community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA), a potentially deadly bacterial infection that is resistant to antibiotic treatment, more than tripled between 1997 and 2006, according to a report published in the July issue of Infection Control and Hospital Epidemiology, the journal of the Society for Healthcare Epidemiology of America.

Most cases of MRSA are acquired in hospitals, nursing homes, or other healthcare facilities. But in recent years public health experts have become increasingly concerned about MRSA infections acquired in community settings like homes, schools, and neighborhoods.

During the study period 3,579 people were admitted to New York City hospitals with CA-MRSA. The rate of CA-MRSA increased from 113 people in 1997, a rate of about 1.5 cases per 100,000 people, to 875 admissions in 2006, a rate of 5.3 per 100,000. Overall, about 20 percent of all MRSA hospitalizations over the study period were community acquired, the study found.

"These findings suggest a substantial increase in the rate of hospitalization with community-acquired MRSA in New York City since 1997," said Amanda Farr, MPH, one of the study's authors. This research was done in collaboration between the New York City Department of Health and Mental Hygiene and Columbia University's Mailman School of Public Health.

When compared with other hospitalizations in the study period, researchers noted that men, children, people with diabetes, people with HIV, and the homeless were more likely to be hospitalized with CA-MRSA than the general population. Residents of the Bronx also had substantially higher rates of CA-MRSA hospitalization than those of other New York City boroughs, likely impacted by a lack of access to primary care health services.

The authors speculated at the increased risk associated with these demographics and co-morbidities. Skin infections and sores are common among people with HIV and diabetes and could open the door to MRSA infection. Males and children may be at higher risk because they are more likely to play contact sports, which are associated with an increase risk of spreading bacteria. Persons that are homeless may have limited access to healthcare, as well as have other risk factors such as lack of personal hygiene and sharing personal items in shelter settings.

The findings suggest that public health efforts to curb community-acquired MRSA should be targeted to high-risk groups.

"Departments of health should educate homeless shelters about CA-MRSA, ways to recognize exposures that lead to transmission and signs and symptoms that should prompt people to seek medical care," the researchers write. "Programs to increase awareness are also needed in the Bronx and other high-risk areas to help residents and healthcare providers recognize signs and symptoms of early infection and implement prompt treatment as well as conduct proper wound care, especially in HIV-positive persons and those with diabetes."

The study reviewed administrative data submitted to New York State Department of Health's Statewide Planning and Research Cooperative System, a reporting system established in 1979 as a result of cooperation between the healthcare industry and government.


Contact: Tamara Moore
Society for Healthcare Epidemiology of America

Related medicine news :

1. As Obesity Rates Rise, Cases of Kidney Stones Double: Study
2. Asthma Cases Continue to Rise in U.S., Affecting Millions
3. Pneumococcal disease: More cases but fewer deaths
4. Screening programs detect cases of undiagnosed rheumatic heart disease in low-resource countries
5. Older Dads May Pass on Longevity to Kids, Study Finds
6. 3-center study identifies main causes of unprofessional behavior among hospitalists
7. Multi-center clinical study intensifies first strike at high-risk cancer in kids
8. A study shows that mosaicism is gaining ground in cancer research
9. Sleep apnea persisting into teens can impact life skills, study finds
10. WSU study finds overwhelming evidence of hidden heart disease in hypertensive African-Americans
11. Docs Arent Coaching Overweight Kids on How to Slim Down: Study
Post Your Comments:
(Date:12/1/2015)... , ... December 01, 2015 , ... According to an ... groups has filed a discrimination claim against the U.S. Department of Health and Human ... Affordable Care Act (ACA) plans are breaking the clause in the law prohibiting the ...
(Date:12/1/2015)... ... December 01, 2015 , ... Califia Farms , one ... its iconic bottle has won top honors in Beverage World Magazine’s Global Packaging Design ... announced that it has been selected as a 2015 U.S.A. Taste Champion in the ...
(Date:12/1/2015)... ... , ... Growth in medical payments per workers’ compensation claim in Louisiana slowed ... nonhospital care, according to a recent study by the Workers Compensation Research Institute (WCRI). ... medical payments per claim with more than seven days of lost time continued to ...
(Date:12/1/2015)... ... December 01, 2015 , ... CloudLIMS today announced ... Bridge Business Awards under the New Products and Services category for its innovative ... sample management software that helps labs organize data and track samples with ...
(Date:12/1/2015)... ... December 01, 2015 , ... Diabetic foot wounds ... Podiatrists are well aware that psychology-based patient non-compliance (disobedience of a health care ... to diseases of the diabetic foot. The American Board of Multiple Specialties ...
Breaking Medicine News(10 mins):
(Date:12/1/2015)... 1, 2015 --> ... report "Nucleic Acid Labeling Market by Product (Reagents & ... Primer, In Vitro Transcription, Reverse Transcription, End Labeling), by ... The global market is expected to reach USD 1,925.7 ... growing at a CAGR of 8.65%. Browse ...
(Date:12/1/2015)... Russia has always been a country of choice for ... Europe in 2015 were tested in phase II-III ... has always been a country of choice for global multi-center phase ... in 2015 were tested in phase II-III clinical trials ... always been a country of choice for global multi-center phase III clinical ...
(Date:12/1/2015)... Dec. 1, 2015 Relmada Therapeutics, Inc. (OTCQB: RLMD), ... chronic pain, announced today that the company will present at ... December 1-3 at the Luxe Sunset Boulevard Hotel in ... CEO of Relmada Therapeutics, will present on Thursday, December 3, ... . Please register at least 10 minutes prior ...
Breaking Medicine Technology: